| |
original article |
Date |
Title |
Authors All Authors |
| 1 |
[GO] |
2024―Oct―28 |
Influenza in Australia before, during and after the COVID-19 pandemic |
Ian G. Barr |
| 2 |
[GO] |
2024―Oct―28 |
COVID-19 vaccine effectiveness monitoring in Australia |
Bette Liu |
| 3 |
[GO] |
2024―Oct―28 |
Recent pandemics and informed predictions |
Stanley Perlman |
| 4 |
[GO] |
2024―Aug―29 |
Corrigendum to: An update on Long COVID |
Gary Grohmann, Robert Booy |
| 5 |
[GO] |
2024―Aug―19 |
High pathogenicity avian influenza in Australia and beyond: could avian influenza cause the next human pandemic? |
Megan Airey, Kirsty R. Short |
| 6 |
[GO] |
2024―Mar―22 |
Cellular signalling by SARS-CoV-2 spike protein |
Nicholas P. Gracie, Lachlan Y. S. Lai, Timothy P. Newsome |
| 7 |
[GO] |
2024―Mar―21 |
Contextualising COVID-19 in 2024 |
Gregory Walker, William Rawlinson |
| 8 |
[GO] |
2024―Mar―19 |
Pandemic lessons learned and future public health strategies |
Brett Sutton |
| 9 |
[GO] |
2024―Mar―15 |
Australia’s COVID-19 vaccine journey: progress and future perspectives |
James A. Triccas, Megan C. Steain |
| 10 |
[GO] |
2024―Mar―15 |
An update on Long COVID |
Gary Grohmann, Robert Booy |
| 11 |
[GO] |
2024―Mar―13 |
Wastewater-based SARS-CoV-2 surveillance and sequencing |
Alice Michie |
| 12 |
[GO] |
2024―Mar―08 |
The evolving epidemiology of SARS-CoV-2 |
Catherine M. Bennett, Hassan Vally |
| 13 |
[GO] |
2024―Mar―05 |
A brief survey of interventional agents intended to treat Long COVID |
Ross T. Barnard, Evan B. Siegel |
| 14 |
[GO] |
2023―Nov―16 |
The 2020 İzmir earthquake and its effect on COVID-19 cases |
Seyfi Durmaz, Gönül Aslan, Raika Durusoy, Candan Çiçek |
| 15 |
[GO] |
2023―Jul―14 |
Redevelopment of undergraduate food microbiology capstone projects for unprecedented emergency remote teaching during the COVID-19 pandemic: then and now |
Yianna Zhang, Chaminda Senaka Ranadheera |
| 16 |
[GO] |
2023―May―18 |
Long COVID |
Kirsty R. Short |
| 17 |
[GO] |
2022―Apr―28 |
Reflections from Melbourne, the world’s most locked-down city, through the COVID-19 pandemic and beyond |
Ian Macreadie |
| 18 |
[GO] |
2022―Apr―14 |
Vaccine technologies used to develop COVID-19 vaccines |
Paul Selleck, Ian Macreadie |
| 19 |
[GO] |
2021―Nov―19 |
COVID-19 in Fiji |
Patrick C Reading, Richard A Strugnell |
| 20 |
[GO] |
2021―Nov―11 |
Avian influenza H5N1: still a pandemic threat? |
Paul F Horwood |
| 21 |
[GO] |
2021―Oct―29 |
Development of container laboratories in response to COVID-19 |
Russell Cole |
| 22 |
[GO] |
2021―Sep―07 |
Reflections on the COVID-19 pandemic from a university academic |
Ian Macreadie |
| 23 |
[GO] |
2021―May―27 |
Lipids, statins and susceptibility to SARS-CoV-2 and influenza A viruses |
Melissa Carabott, Ryan Case, Sudip Dhakal, Ian Macreadie |
| 24 |
[GO] |
2021―Apr―27 |
Corrigendum to: Therapeutics for COVID-19: established and in development |
Kasha P Singh, Joe Sasadeusz, Sharon R Lewin, Jennifer Audsley |
| 25 |
[GO] |
2021―Apr―27 |
Contextualising SARS Coronavirus 2 and COVID-19 |
William Rawlinson |
| 26 |
[GO] |
2021―Apr―12 |
Perspectives for antivirals to limit SARS-CoV-2 infection (COVID-19) |
Erik De Clercq |
| 27 |
[GO] |
2021―Apr―12 |
Vaccination for COVID-19 control and considerations for Australia |
Raina MacIntyre |
| 28 |
[GO] |
2021―Apr―12 |
Role of testing for the COVID-19 response in Aboriginal, Torres Strait Islander and regional populations |
David Speers |
| 29 |
[GO] |
2021―Apr―12 |
The threat of zoonotic coronaviruses |
Matthew J Gartner, Kanta Subbarao |
| 30 |
[GO] |
2021―Apr―12 |
Wastewater monitoring for SARS-CoV-2 |
Erica Donner, Arash Zamyadi, Aaron Jex, Michael Short, Barbara Drigo, David McCarthy, et al. (+11) Nicholas Crosbie, Warish Ahmed, Jochen Mueller, Kevin Thomas, Paul Monis, Alex Keegan, Maneesha Ginige, Philip Hugenholtz, Gene Tyson, Kelly Hill, Linda Blackall |
| 31 |
[GO] |
2021―Apr―12 |
Long-term and short-term immunity to SARS-CoV-2: why it matters |
John Zaunders, Chansavath Phetsouphanh |
| 32 |
[GO] |
2021―Apr―12 |
Responding to the pandemic at a national and state public health level |
Sonya Bennett |
| 33 |
[GO] |
2021―Apr―09 |
Genome sequencing and its use in public health responses to COVID-19 |
John-Sebastian Eden |
| 34 |
[GO] |
2021―Apr―09 |
COVID-19 in animals: contact with humans and potential transmissions |
Paul Selleck |
| 35 |
[GO] |
2021―Apr―09 |
Genes of SARS-CoV-2 and emerging variants |
Sudip Dhakal, Ian Macreadie |
| 36 |
[GO] |
2020―Nov―10 |
Therapeutics for COVID-19: established and in development |
Kasha P Singh, Joe Sasadeusz, Sharon R Lewin, Jennifer Audsley |
| 37 |
[GO] |
2020―Oct―27 |
What history teaches us about vaccines and pandemics |
David Isaacs |
| 38 |
[GO] |
2020―Oct―22 |
Understanding the SARS-CoV-2 pandemic as evolution in action |
Will Cairns |
| 39 |
[GO] |
2020―Oct―07 |
The 1918 Spanish influenza pandemic: plus ça change, plus ça change, plus c’est la même chose |
Paul Selleck, Ross Barnard |
| 40 |
[GO] |
2020―Aug―18 |
The SARS-CoV-2 ‘perfect storm |
Annaleise R Howard-Jones, Jen Kok |
| 41 |
[GO] |
2020―May―27 |
Disease X ver1.0: COVID-19 |
Paul R Young |
| 42 |
[GO] |
2020―Apr―03 |
What serosurveillance studies tell us about the 2009 influenza pandemic |
Gary K Dowse, Ian Barr |
| 43 |
[GO] |
2020―Apr―03 |
How did the 2009 pandemic compare with previous pandemics? |
John D Matthews |
| 44 |
[GO] |
2020―Apr―03 |
Diagnosis of influenza following the first wave of pandemic (H1N1) 2009 influenza |
Jen Kok, Dominic E Dwyer |
| 45 |
[GO] |
2020―Apr―03 |
Pandemic H1N1 2009 influenza in pigs in Australia |
Frank YK Wong, Yi-Mo Deng |
| 46 |
[GO] |
2020―Apr―03 |
Laboratory diagnosis of influenza and the impact of the pandemic (H1N1) 2009 virus |
Jen Kok, David W Smith, Dominic E Dwyer |
| 47 |
[GO] |
2020―Apr―03 |
Antiviral drug resistance in seasonal and pandemic influenza |
Aeron C Hurt |
| 48 |
[GO] |
2020―Apr―03 |
The origins of pandemic influenza ? a perspective |
Graeme Laver |
| 49 |
[GO] |
2020―Apr―03 |
Clinical impact of influenza - lessons learnt from the pandemic influenza A (H1N1) 2009 |
Alex Dierig, Gulam Khandaker, Robert Booy |
| 50 |
[GO] |
2020―Apr―03 |
H1N1 2009 pandemic influenza in Indigenous Australians |
Peter Markey, Jiunn-Yih Su, Andre Wattiaux, James Trauer, Vicki Krause |
| 51 |
[GO] |
2020―Apr―03 |
Development and testing of the Australian pandemic influenza vaccine - a timely response |
Steven Rockman, Peter Schoofs, Michael Greenberg |
| 52 |
[GO] |
2020―Apr―03 |
Regulatory issues in pandemic influenza vaccine development |
Gary Grohmann |
| 53 |
[GO] |
2020―Apr―03 |
Pandemic planning: the Australian response |
Moira McKinnon |
| 54 |
[GO] |
2020―Apr―03 |
Development of an Australian pandemic vaccine |
David Ryan |
| 55 |
[GO] |
2020―Apr―03 |
T-cell immunity against the A(H1N1) 2009 pandemic virus |
Sophie A Valkenburg, Karen Laurie, Anne Kelso, Stephen J Turner, Peter C Doherty, Katherine Kedzierska |
| 56 |
[GO] |
2020―Apr―03 |
‘Dengue: Australia’s other pandemic’ |
Scott A Rithchie |
| 57 |
[GO] |
2020―Apr―03 |
Preparing for the influenza pandemic: the government response |
Moira McKinnon |
| 58 |
[GO] |
2020―Mar―17 |
COVID-19: a novel zoonotic disease caused by a coronavirus from China: what we know and what we don't |
John S Mackenzie, David W Smith |
